A site-specific integrated Col2.3GFP reporter identifies osteoblasts within mineralized tissue formed in vivo by human embryonic stem cells

Stem Cells Translational Medicine

Volumn 3, Issue 10, 2014, Pages 1125-1137

  Xin, Xiaonan ^a   Jiang, Xi ^a   Wang, Liping ^a   Stover, Mary Louise ^a   Zhan, Shuning ^a   Huang, Jianping ^a   Jon Goldberg, A ^a   Liu, Yongxing ^a   Kuhn, Liisa ^a   Reichenberger, Ernst J ^a   Rowe, David W ^a   Lichtler, Alexander C ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Bone; Gene targeting; Mesenchymal stem cell; Osteoblast; Zinc fingers

Indexed keywords

ALKALINE PHOSPHATASE; BONE SIALOPROTEIN; GREEN FLUORESCENT PROTEIN; ZINC FINGER NUCLEASE; COLLAGEN TYPE 1; COLLAGEN TYPE I, ALPHA 1 CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; KARYOTYPING; MOUSE; NONHUMAN; OSTEOBLAST; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TERATOMA; ANIMAL; BONE MATRIX; CYTOLOGY; GENETICS; IMMUNOHISTOCHEMISTRY; PHYSIOLOGY; PLURIPOTENT STEM CELL; REPORTER GENE; XENOGRAFT;

ANIMALS; BONE MATRIX; CELL DIFFERENTIATION; COLLAGEN TYPE I; EMBRYONIC STEM CELLS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; OSTEOBLASTS; PLURIPOTENT STEM CELLS; RATS;

EID: 84908021919     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0128     Document Type: Article

References (23)

1. Yamanaka S. Induced pluripotent stem cells: Past, present, and future. Cell Stem Cell 2012;10:678-684.
2. Urnov FD, Miller JC, Lee YL et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 2005;435:646-651.
3. Hockemeyer D, Soldner F, Beard C et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol 2009;27:851-857.
4. Soldner F, Laganière J, Cheng AW et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 2011;146:318- 331.
5. Barberi T, Willis LM, Socci ND et al. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med 2005;2:0554-0560.
6. Bielby RCBA, Boccaccini AR, Polak JM et al. In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng 2004;10: 1518-1525.
7. Boyd NL, Robbins KR, Dhara SK et al. Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells. Tissue Eng Part A 2009;15:1897-1907.
8. Arpornmaeklong P, Brown SE, Wang Z et al. Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells Dev 2009;18: 955-968.
9. Kuznetsov SA, Cherman N, Robey PG. In vivo bone formation by progeny of human embryonic stem cells. Stem Cells Dev 2011;20:269-287.
10. Bilic-Curcic I, Kalajzic Z, Wang L et al. Origins of endothelial and osteogenic cells in the subcutaneous collagen gel implant. Bone 2005; 37:678-687.
11. Wang L, Liu Y, Kalajzic Z et al. Heterogeneity of engrafted bone-lining cells after systemic and local transplantation. Blood 2005; 106:3650-3657.
12. Jiang X, Kalajzic Z, Maye P et al. Histological analysis of GFP expression in murine bone. J Histochem Cytochem 2005;53:593-602.
13. Kalajzic I, Kalajzic Z, KaliternaMet al. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 2002;17:15-25.
14. Yin D,WangZ, GaoQet al. Determination of the fate and contribution of ex vivo expanded human bone marrow stem and progenitor cells for bone formation by 2.3ColGFP. Mol Ther 2009;17:1967-1978.
15. Lombardo A, Genovese P, Beausejour CMet al. Gene editing inhumanstem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 2007; 25:1298-1306.
16. Kuhn LT, Liu Y, Boyd NL et al. Developmental-like bone regeneration by human embryonic stem cell-derived mesenchymal cells. Tissue Eng Part A 2014;20:365-377.
17. Lois C, Hong EJ, Pease S et al. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002;295:868-872.
18. Shaner NC, Campbell RE, Steinbach PA et al. Improved monomeric red, orange and yellowfluorescent proteins derived fromDiscosoma sp. red fluorescent protein. Nat Biotechnol 2004;22:1567-1572.
19. Ellis J, Yao S. Retrovirus silencing and vector design: Relevance to normal and cancer stem cells? Curr Gene Ther 2005;5:367-373.
20. Yao S, Sukonnik T, Kean T et al. Retrovirus silencing, variegation, extinction, andmemoryare controlled by a dynamic interplay ofmultiple epigenetic modifications. Mol Ther 2004;10:27-36.
21. Suzuki M, Kasai K, Saeki Y. Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin. J Virol 2006;80:3293-3300.
22. Shaner NC, Steinbach PA, Tsien RY. A guide to choosing fluorescent proteins. Nat Methods 2005;2:905-909.
23. Chang MK, Raggatt LJ, Alexander KA et al. Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol 2008;181:1232-1244.